Literature DB >> 19169820

New clinical method for distinguishing D-IBS from other gastrointestinal conditions causing diarrhea: the LA/IBS diagnostic strategy.

Mark Pimentel1, Laura Hwang, Gil Y Melmed, Kimberly Low, Eric Vasiliauskas, Andrew Ippoliti, Janet Yang, Sheila Lezcano, Jeffrey L Conklin, Ara Sahakian.   

Abstract

Modern methods of diagnosing diarrhea-predominant irritable bowel syndrome (D-IBS) require a "diagnosis of exclusion" approach. In this study we aim to test the diagnostic ability of using the fluctuation of frequency and consistency of bowel patterns in IBS to discriminate it from other causes of diarrhea. Eligible subjects were asked to complete a questionnaire on the changes in form and frequency of bowel habits by time. The primary endpoint was to evaluate the diagnostic effectiveness of having irregularly irregular bowel function and form as more characteristic of IBS versus non-IBS causes. Patients were prospectively recruited from a tertiary care GI clinic. Subjects had to have diarrhea as their primary complaint. In the case of IBS, D-IBS subjects were recruited. Subjects with celiac disease, Crohn's and ulcerative colitis were recruited for comparison and were categorically called "non-IBS." Non-IBS subjects could not have a recent history of blood in stool or a history of bowel surgery, fistulae or narcotic use. Sixty-two IBS and 37 non-IBS subjects were recruited. Among the 62 IBS subjects, 49 (79%) stated that their bowel habits varied in form and frequency on a daily basis compared to 35% in non-IBS subjects (OR = 8.9, CI = 3.5-22.5, P < 0.00001). When subjects were compared by the number of different stool forms they had witnessed in the prior week, IBS subjects noted 3.58 +/- 0.19 types and non-IBS reported 2.35 +/- 0.16 (P < 0.00001). Using > or = 3 stool forms per week as a method of discriminating IBS from non-IBS, 50 out of 62 subjects with IBS (81%) reported this greater number of forms compared to 15 out of 37 (41%) non-IBS subjects (sensitivity = 0.81; specificity = 0.60). The use of this simple tool that identifies an irregularly irregular bowel form and function is successful in separating D-IBS from non-IBS subjects.

Entities:  

Mesh:

Year:  2009        PMID: 19169820     DOI: 10.1007/s10620-008-0694-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  15 in total

1.  Small intestinal bacterial overgrowth is associated with irritable bowel syndrome: the cart lands squarely in front of the horse.

Authors:  M P Jones; R Craig; E Olinger
Journal:  Am J Gastroenterol       Date:  2001-11       Impact factor: 10.864

2.  Guidelines--Rome III Diagnostic Criteria for Functional Gastrointestinal Disorders.

Authors: 
Journal:  J Gastrointestin Liver Dis       Date:  2006-09       Impact factor: 2.008

Review 3.  Functional bowel disorders and functional abdominal pain.

Authors:  W G Thompson; G F Longstreth; D A Drossman; K W Heaton; E J Irvine; S A Müller-Lissner
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

4.  Physicians' attitudes and practices in the evaluation and treatment of irritable bowel syndrome.

Authors:  Brian E Lacy; Justin Rosemore; Douglas Robertson; David A Corbin; Maria Grau; Michael D Crowell
Journal:  Scand J Gastroenterol       Date:  2006-08       Impact factor: 2.423

Review 5.  Inclusion and exclusion criteria of importance in irritable bowel syndrome trials.

Authors:  J F Bergmann
Journal:  Am J Med       Date:  1999-11-08       Impact factor: 4.965

6.  Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria.

Authors:  Gilles Bommelaer; Thierry Poynard; Claude Le Pen; Anne-Françoise Gaudin; Frédérique Maurel; Gaël Priol; Michel Amouretti; Jacques Frexinos; Philippe Ruszniewski; Abdelkader El Hasnaoui
Journal:  Gastroenterol Clin Biol       Date:  2004 Jun-Jul

Review 7.  Impact of irritable bowel syndrome: prevalence and effect on health-related quality of life.

Authors:  Hashem B El-Serag
Journal:  Rev Gastroenterol Disord       Date:  2003

8.  Prevalence of irritable bowel syndrome: a community survey.

Authors:  Sue Wilson; Lesley Roberts; Andrea Roalfe; Pam Bridge; Sukhdev Singh
Journal:  Br J Gen Pract       Date:  2004-07       Impact factor: 5.386

9.  The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community.

Authors:  Kok-Ann Gwee; Sharon Wee; Mee-Lian Wong; Damian J C Png
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

Review 10.  Clinical assessment of irritable bowel syndrome.

Authors:  Tony J Lembo; Rebecca N Fink
Journal:  J Clin Gastroenterol       Date:  2002-07       Impact factor: 3.062

View more
  14 in total

1.  IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment.

Authors:  Olafur S Palsson; Jeffrey S Baggish; Marsha J Turner; William E Whitehead
Journal:  Am J Gastroenterol       Date:  2011-11-08       Impact factor: 10.864

Review 2.  Irritable bowel syndrome.

Authors:  Paul Enck; Qasim Aziz; Giovanni Barbara; Adam D Farmer; Shin Fukudo; Emeran A Mayer; Beate Niesler; Eamonn M M Quigley; Mirjana Rajilić-Stojanović; Michael Schemann; Juliane Schwille-Kiuntke; Magnus Simren; Stephan Zipfel; Robin C Spiller
Journal:  Nat Rev Dis Primers       Date:  2016-03-24       Impact factor: 52.329

Review 3.  Irritable bowel syndrome: a clinical review.

Authors:  Rosa L S Soares
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

4.  Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model.

Authors:  Mark Pimentel; Walter Morales; Venkata Pokkunuri; Constantinos Brikos; Sun Moon Kim; Seong Eun Kim; Konstantinos Triantafyllou; Stacy Weitsman; Zachary Marsh; Emily Marsh; Kathleen S Chua; Shanthi Srinivasan; Gillian M Barlow; Christopher Chang
Journal:  Dig Dis Sci       Date:  2014-11-26       Impact factor: 3.199

Review 5.  Antibiotics for irritable bowel syndrome: rationale and current evidence.

Authors:  Amit H Sachdev; Mark Pimentel
Journal:  Curr Gastroenterol Rep       Date:  2012-10

6.  Irritable bowel syndrome: diagnostic approaches in clinical practice.

Authors:  Eugene J Burbige
Journal:  Clin Exp Gastroenterol       Date:  2010-09-17

7.  Healthy control subjects are poorly defined in case-control studies of irritable bowel syndrome.

Authors:  Shireen Ghorbani; Amir Nejad; David Law; Kathleen S Chua; Meridythe M Amichai; Mark Pimentel
Journal:  Ann Gastroenterol       Date:  2015 Jan-Mar

Review 8.  Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment.

Authors:  Robin Spiller
Journal:  F1000Res       Date:  2016-04-29

9.  Role of Cytolethal Distending Toxin in Altered Stool Form and Bowel Phenotypes in a Rat Model of Post-infectious Irritable Bowel Syndrome.

Authors:  Venkata Pokkunuri; Mark Pimentel; Walter Morales; Sam-Ryong Jee; Joel Alpern; Stacy Weitsman; Zachary Marsh; Kimberly Low; Laura Hwang; Reza Khoshini; Gillian M Barlow; Hanlin Wang; Christopher Chang
Journal:  J Neurogastroenterol Motil       Date:  2012-10-09       Impact factor: 4.924

Review 10.  Therapeutic significance and pharmacological activities of antidiarrheal medicinal plants mention in Ayurveda: A review.

Authors:  Ashish Mishra; Ankit Seth; Santosh Kumar Maurya
Journal:  J Intercult Ethnopharmacol       Date:  2016-05-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.